Embedded Files
The North America contrast media injectors market is expected to reach US$ 507.8 Mn in 2027 from US$ 271.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.
Fueled by a rising tide of approvals for contrast agents and a growing population grappling with chronic diseases, the North America contrast media injectors market is poised for significant expansion. In societies facing the challenges of an aging demographic and the pervasive impact of long-lasting medical conditions, technological progress becomes indispensable for maintaining quality of life without escalating costs. Chronic diseases, defined by their duration of a year or more and the necessity for ongoing medical care or limitations in daily activities, encompass conditions like cancer, heart disease, and musculoskeletal disorders. These conditions frequently necessitate various medical imaging techniques for accurate diagnosis and effective treatment monitoring.
The economic burden of chronic diseases is substantial. Data from the National Center for Chronic Disease Prevention and Health Promotion reveals an annual healthcare expenditure of US$3.3 trillion attributed to these conditions. The prevalence of chronic diseases is also striking. The Centers for Disease Control & Prevention (CDC) indicates that 6 in 10 adults in the US live with at least one chronic disease, with 4 in 10 adults facing two or more. Further highlighting the scale of the issue, the U.S. Department of Health and Human Services reports that 133 million Americans are affected by a chronic illness.
The impact of chronic diseases extends deeply into the healthcare system. They account for a significant majority of hospital admissions (81%), prescription fills (91%), and physician visits (76%). The escalating costs associated with chronic diseases place a financial strain on both U.S. employers and employees through increased health insurance premiums and greater utilization of healthcare services. Consequently, the expanding pool of individuals with chronic diseases who require medical imaging for diagnosis and management is projected to be a key driver in boosting the growth of the North America contrast media injectors market in the US in the years ahead.
Within North America, the US is anticipated to be the frontrunner in market growth. This dominance is attributed to the increasing rate of approvals for innovative contrast agents and the substantial number of individuals living with chronic diseases. However, the potential for side effects associated with contrast media agents is expected to act as a moderating factor on market expansion. Nevertheless, considering the interplay of these factors, the US market is likely to contribute the largest share to the North America contrast media injectors market throughout the forecast period.
North America Contrast Media Injectors – Market Segmentation
North America contrast media injectors market By Product
Injector Systems
MRI Injector Systems
CT Injector Systems
Angiography Injector Systems
Consumables
Injector Heads
Single Head Injectors
Dual Head Injectors
Syringe less Injectors
Tubing
Syringes
Other Consumables
Accessories
North America contrast media injectors market By Application
Interventional Cardiology
Interventional Radiology
Radiology
North America contrast media injectors market By Geography
North America
US
Canada
Mexico
North America contrast media injectors market Company Profiles
Boston Scientific Corporation
Shenzhen Xinguan Electromechanical Co. Ltd.
ulrich GmbH & Co.KG.
APOLLO RT Co. Ltd.
Bracco Imaging S.p.A.
Guerbet SA
Cook Medical Incorporated
Smiths Medical
Sino Medical-Device Technology Co., Ltd.,
Bayer AG
Nemoto Kyorindo Co., Ltd.
General Electric
AngioDynamics.
North America contrast media injectors market Strategic Insights
Strategic insights for the North America contrast media injectors market provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the North America contrast media injectors market.
Other Reports:
Europe Surgical Robots Market: https://sites.google.com/view/surgical-robots-markete/home
Europe Polyacrylamide Market: https://business-news-insights.blogspot.com/2025/05/europe-polyacrylamide-market-growth-by.html
Europe Ice Cream Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/53
Europe Dairy Alternatives Market: https://penzu.com/p/8ab0c5ae5a2fd1ce
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Page updated
Google Sites
Report abuse